| Clinical features and outcomes of 98 patients hospitalized with SARS-CoV-2 infection in Daegu, South Korea: a brief descriptive study KS Hong, KH Lee, JH Chung, KC Shin, EY Choi, HJ Jin, JG Jang, W Lee, ... Yonsei medical journal 61 (5), 431, 2020 | 168 | 2020 |
| COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm W Lee, JH Ahn, HH Park, HN Kim, H Kim, Y Yoo, H Shin, KS Hong, ... Signal transduction and targeted therapy 5 (1), 186, 2020 | 123 | 2020 |
| Prognostic accuracy of the SIRS, qSOFA, and NEWS for early detection of clinical deterioration in SARS-CoV-2 infected patients JG Jang, J Hur, KS Hong, W Lee, JH Ahn Journal of Korean medical science 35 (25), 2020 | 111 | 2020 |
| Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm YY Lee, HH Park, W Park, H Kim, JG Jang, KS Hong, JY Lee, HS Seo, ... Biomaterials 267, 120389, 2021 | 110 | 2021 |
| The risk of diabetes on clinical outcomes in patients with coronavirus disease 2019: a retrospective cohort study SM Chung, YY Lee, E Ha, JS Yoon, KC Won, HW Lee, J Hur, KS Hong, ... Diabetes & metabolism journal 44 (3), 405, 2020 | 82 | 2020 |
| Diagnosis and treatment of multidrug-resistant tuberculosis JG Jang, JH Chung Yeungnam University journal of medicine 37 (4), 277, 2020 | 81 | 2020 |
| Prognostic factors for severe coronavirus disease 2019 in Daegu, Korea JG Jang, J Hur, EY Choi, KS Hong, W Lee, JH Ahn Journal of Korean medical science 35 (23), 2020 | 80 | 2020 |
| PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses HH Park, H Kim, HS Lee, EU Seo, JE Kim, JH Lee, YH Mun, SY Yoo, J An, ... Biomaterials 273, 120827, 2021 | 35 | 2021 |
| A case of nonthrombotic pulmonary embolism after facial injection of hyaluronic acid in an illegal cosmetic procedure JG Jang, KS Hong, EY Choi Tuberculosis and Respiratory Diseases 77 (2), 90, 2014 | 33 | 2014 |
| The effects of repeated inhaler device handling education in COPD patients: a prospective cohort study JH Ahn, JH Chung, KC Shin, HJ Jin, JG Jang, MS Lee, KH Lee Scientific reports 10 (1), 19676, 2020 | 30 | 2020 |
| Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm H Kim, HS Lee, JH Ahn, KS Hong, JG Jang, J An, YH Mun, SY Yoo, ... Nano Today 38, 101149, 2021 | 27 | 2021 |
| A case of solitary fibrous pleura tumor associated with severe hypoglycemia: doege-potter syndrome JG Jang, JH Chung, KS Hong, JH Ahn, JY Lee, JH Jo, DW Lee, KC Shin, ... Tuberculosis and respiratory diseases 78 (2), 120, 2015 | 23 | 2015 |
| Clinical impact of blood pressure variability in patients with COVID-19 and hypertension JH Nam, JI Park, BJ Kim, HT Kim, JH Lee, CH Lee, JW Son, U Kim, ... Blood Pressure Monitoring 26 (5), 348-356, 2021 | 22 | 2021 |
| Quantitative assessment of chest CT patterns in COVID-19 and bacterial pneumonia patients: a deep learning perspective M Kang, KS Hong, P Chikontwe, M Luna, JG Jang, J Park, KC Shin, ... Journal of Korean medical science 36 (5), 2021 | 19 | 2021 |
| Early hydroxychloroquine administration for rapid severe acute respiratory syndrome coronavirus 2 eradication KS Hong, JG Jang, J Hur, JH Lee, HN Kim, W Lee, JH Ahn Infection & chemotherapy 52 (3), 396, 2020 | 18 | 2020 |
| Initial experience in CT-guided percutaneous transthoracic needle biopsy of lung lesions performed by a pulmonologist JH Ahn, JG Jang Journal of clinical medicine 8 (6), 821, 2019 | 18 | 2019 |
| Incidence and prognostic factors of respiratory viral infections in severe acute exacerbation of chronic obstructive pulmonary disease JG Jang, JH Ahn, HJ Jin International Journal of Chronic Obstructive Pulmonary Disease, 1265-1273, 2021 | 16 | 2021 |
| Reasons and risk factors for readmission following hospitalization for community-acquired pneumonia in South Korea JG Jang, JH Ahn Tuberculosis and Respiratory Diseases 83 (2), 147, 2020 | 15 | 2020 |
| Foreign-body aspiration into the lower airways in adults; multicenter study G Jang, JW Song, HJ Kim, EJ Kim, JG Jang, SI Cha Plos one 17 (7), e0269493, 2022 | 14 | 2022 |
| GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro KS Hong, JH Ahn, JG Jang, JH Lee, HN Kim, D Kim, W Lee Signal Transduction and Targeted Therapy 5 (1), 267, 2020 | 14 | 2020 |
